They represent brand-attributed clinical perspective - not a peer-reviewed published finding about collagen deficiency in GLP-1 patients specifically
The medication works by slowing digestion and affecting appetite signals, so increasing the dose too quickly overwhelms the body
Next Step: Ready to see if a personalized program is right for you
Others may produce formulations with variable potency that make dosing less predictable regardless of timing
Nausea, vomiting, diarrhea, constipation, and stomach discomfort are common across the class, particularly early in treatment
Clinical trials have reported gastrointestinal side effects as common adverse events with incretin-based therapies, including nausea and vomiting, which may affect patient adherence